Literature DB >> 23405359

Complete Genome Sequence of a Novel Recombinant Human Norovirus Genogroup II Genotype 4 Strain Associated with an Epidemic during Summer of 2012 in Hong Kong.

Martin C W Chan1, Paul K S Chan.   

Abstract

Beginning in July 2012, a community-wide increase in the number of norovirus-associated acute gastroenteritis cases was observed during the summer months in Hong Kong. Here, we report the complete genome sequence of a novel recombinant norovirus genogroup II genotype 4 (GII.4) strain, named "2012v," which is associated with this "early" epidemic outside the usual winter season.

Entities:  

Year:  2013        PMID: 23405359      PMCID: PMC3569363          DOI: 10.1128/genomeA.00140-12

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Human norovirus is a leading cause of acute nonbacterial gastroenteritis worldwide in all age groups, in both developed and developing countries (1, 2). In the United States, among the food-borne outbreaks that were submitted to the norovirus outbreak surveillance system CaliciNet during 2009–2011, >70% of outbreaks were attributed to norovirus genogroup II genotype 4 (GII.4) strains (3). Although norovirus infections are generally mild and self-limiting in otherwise healthy individuals, severe disease progression may occur, especially in cases caused by GII.4 strains (4). In Hong Kong, two epidemics with exceedingly high norovirus activity outside the winter months were observed in the past decade: one in 2004 (September–October) (5) and another in 2006 (June–July) (6). Notably, the two atypical summer epidemics coincided with the emergence and subsequent predominance of novel GII.4 strains, namely 2004v (Hunter/Sakai) and 2006b (Minerva), named for their respective years. Beginning in July 2012, a community-wide increase in the number of norovirus-associated acute gastroenteritis cases was observed in Hong Kong (7). In this “early” epidemic, norovirus activity peaked in August and subsided in October—in other words, outside the usual winter season. Here, we report the complete genome sequence of a novel recombinant norovirus GII.4 strain that was associated with this epidemic during the summer of 2012 in Hong Kong. Viral RNA was extracted from a 10% (wt/vol) stool suspension in phosphate-buffered saline using PureLink viral RNA/DNA mini kit (Life Technologies). The stool specimen was collected at the peak of norovirus activity in mid-August. Purified viral RNA was reverse-transcribed using SuperScript III reverse transcriptase (Life Technologies) with a tagged oligo(dT) primer as we described previously (8). Two overlapping PCR fragments were generated using Phusion High-Fidelity DNA polymerase. The first fragment (~3.4 kb) comprised the complete open reading frame (ORF) 1 except for the RNA-dependent RNA polymerase (RdRp) gene. The second fragment (~4.2 kb) comprised RdRp, viral protein 1 (VP1), and viral protein 2 (VP2) genes, plus a 3′-untranslated region. PCR products were Sanger-sequenced directly using a primer walking approach. The sequence reads were assembled using ChromasPro v.1.7.1 (Technelysium). A detailed PCR protocol and list of primers used are available upon request. Virus typing and phylogenetic analysis using norovirus typing tool v.1.0 (available at http://www.rivm.nl/mpf/norovirus/typingtool) showed that the epidemic was attributed to a recombinant norovirus strain composed of GII.e RdRp and GII.4 VP1. The VP1 clustered most closely with GII.4 2008 and 2010 strains, with nucleotide and amino acid differences of 5% to 6% and 3% to 4%, respectively; this suggests a new strain (9). The complete genome sequence was designated Hu/GII.4/Hong Kong/CUHK3630/2012/CHN and this novel recombinant GII.4 strain was named “2012v.” An earlier study demonstrated that 10 residues on VP1 (S343, T344, R345, A346, K348, N373, D374, D391, G442, and Y443) of norovirus GII.4 VA387 strain formed the interaction interface with histo-blood group antigens (HBGAs), the putative receptors for human norovirus (10). Notably, the 2012v strain contains a novel N373R mutation on the interaction interface not seen in previous GII.4 strains circulating in Hong Kong and elsewhere before 2012. It is therefore very interesting to know whether the newly emerged 2012v strain targets different susceptible populations.

Nucleotide sequence accession number.

The norovirus Hu/GII.4/Hong Kong/CUHK3630/2012/CHN sequence was deposited into GenBank under the accession no. KC175323.
  9 in total

1.  Covariation of major and minor viral capsid proteins in norovirus genogroup II genotype 4 strains.

Authors:  Martin Chi-Wai Chan; Nelson Lee; Wing-Shan Ho; Carmen Oi-Kwan Law; Terrence Chi-Kong Lau; Stephen Kwok-Wing Tsui; Joseph Jao-Yiu Sung
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review.

Authors:  Rishi Desai; Christal D Hembree; Andreas Handel; Jonathan E Matthews; Benjamin W Dickey; Sharla McDonald; Aron J Hall; Umesh D Parashar; Juan S Leon; Benjamin Lopman
Journal:  Clin Infect Dis       Date:  2012-04-04       Impact factor: 9.079

3.  Norovirus classification and proposed strain nomenclature.

Authors:  Du-Ping Zheng; Tamie Ando; Rebecca L Fankhauser; R Suzanne Beard; Roger I Glass; Stephan S Monroe
Journal:  Virology       Date:  2005-12-15       Impact factor: 3.616

4.  Atypical norovirus epidemic in Hong Kong during summer of 2006 caused by a new genogroup II/4 variant.

Authors:  Eric C M Ho; Peter K C Cheng; Angela W L Lau; Ann H Wong; Wilina W L Lim
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

5.  Norovirus-host interaction: multi-selections by human histo-blood group antigens.

Authors:  Ming Tan; Xi Jiang
Journal:  Trends Microbiol       Date:  2011-06-24       Impact factor: 17.079

6.  Correlation of norovirus variants with epidemics of acute viral gastroenteritis in Hong Kong.

Authors:  Eric C M Ho; Peter K C Cheng; Derek A Wong; Angela W L Lau; Wilina W L Lim
Journal:  J Med Virol       Date:  2006-11       Impact factor: 2.327

Review 7.  Progress in understanding norovirus epidemiology.

Authors:  Marion Koopmans
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

8.  Novel surveillance network for norovirus gastroenteritis outbreaks, United States.

Authors:  Everardo Vega; Leslie Barclay; Nicole Gregoricus; Kara Williams; David Lee; Jan Vinjé
Journal:  Emerg Infect Dis       Date:  2011-08       Impact factor: 6.883

Review 9.  Systematic literature review of role of noroviruses in sporadic gastroenteritis.

Authors:  Manish M Patel; Marc-Alain Widdowson; Roger I Glass; Kenichiro Akazawa; Jan Vinjé; Umesh D Parashar
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

  9 in total
  9 in total

1.  The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012.

Authors:  John-Sebastian Eden; Joanne Hewitt; Kun Lee Lim; Maciej F Boni; Juan Merif; Gail Greening; Rodney M Ratcliff; Edward C Holmes; Mark M Tanaka; William D Rawlinson; Peter A White
Journal:  Virology       Date:  2013-12-25       Impact factor: 3.616

2.  Recombination within the pandemic norovirus GII.4 lineage.

Authors:  John-Sebastian Eden; Mark M Tanaka; Maciej F Boni; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

3.  Prevalence and genetic diversity of norovirus genogroup II in children less than 5 years of age with acute gastroenteritis in Tehran, Iran.

Authors:  Mahsa Farsi; Fatemeh Roodbari; Behrooz Nejati; Arash Arashkia; Somayeh Jalilvand; Alireza Nateghian; Aliakbar Rahbarimanesh; Sayed Mahdi Marashi; Zabihollah Shoja
Journal:  Med Microbiol Immunol       Date:  2018-04-04       Impact factor: 3.402

4.  Detection of the pandemic norovirus variant GII.4 Sydney 2012 in Rio Branco, state of Acre, northern Brazil.

Authors:  Luciana Damascena da Silva; Evandro Leite Rodrigues; Maria Silvia Sousa da Lucena; Ian Carlos Gomes de Lima; Darleise de Sousa Oliveira; Luana Silva Soares; Joana D'Arc Pereira Mascarenhas; Alexandre da Costa Linhares; Yvone Benchimol Gabbay
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

5.  Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014.

Authors:  Martin C W Chan; Nelson Lee; Tin-Nok Hung; Kirsty Kwok; Kelton Cheung; Edith K Y Tin; Raymond W M Lai; E Anthony S Nelson; Ting F Leung; Paul K S Chan
Journal:  Nat Commun       Date:  2015-12-02       Impact factor: 14.919

6.  Rapid emergence of novel GII.4 sub-lineages noroviruses associated with outbreaks in Huzhou, China, 2008-2012.

Authors:  Lei Ji; Xiaofang Wu; Wenting Yao; Liping Chen; Deshun Xu; Yuehua Shen; Jiayu Shen; Jiankang Han
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

7.  Novel norovirus recombinants detected in South Africa.

Authors:  Janet Mans; Tanya Y Murray; Maureen B Taylor
Journal:  Virol J       Date:  2014-09-17       Impact factor: 4.099

8.  Norovirus Recombinant Strains Isolated from Gastroenteritis Outbreaks in Southern Brazil, 2004-2011.

Authors:  Tulio Machado Fumian; Juliana da Silva Ribeiro de Andrade; José Paulo Gagliardi Leite; Marize Pereira Miagostovich
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

9.  Characteristics of patients infected with norovirus GII.4 Sydney 2012, Hong Kong, China.

Authors:  Martin C W Chan; Ting F Leung; Angela K Kwok; Nelson Lee; Paul K S Chan
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.